Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid (Q77802531)
Jump to navigation
Jump to search
scientific article published on 01 November 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid |
scientific article published on 01 November 1998 |
Statements
Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid (English)
Browne WL
Wilson WR
Baguley BC
1 November 1998